Ovarian Cancer SPORE Developmental Research Program

Background

The RPCI-UPCI Ovarian Cancer Specialized Programs of Research Excellence (SPORE) supports four Individual Research Projects, four Cores, a Career Enhancement Program (CEP) and a Developmental Research Program (DRP).

The SPORE grant mechanism is aimed at translational research projects. The NIH definition of what constitutes translational research for SPORE applications is:

Translational cancer research transforms scientific discoveries arising from laboratory, clinical, or population studies into clinical applications that reduce cancer incidence, morbidity, and mortality.

The goal of the DRP is to expand the pool of researchers committed to translational ovarian cancer research. Research initiatives that will be funded by the DRP are expected to have a major translational component, including those with an emphasis on etiology, diagnosis, early detection, treatment, or population science. The DRP provides a unique venue for developing cutting-edge new projects by providing significant financial support and active institutional commitment, through a program that is rapidly responsive to new ideas or initiatives. These awards are intended to provide funding for the collection of preliminary data and the development of full projects to be considered for alternate peer-reviewed funding. Funded pilot projects that have the potential to be incorporated as a component of the RPCI-UPCI Ovarian Cancer SPORE are encouraged.

Eligibility

  • Full-time Faculty Member, Associate Professor level or higher
  • Full-time Faculty Member, Assistant Professor with current or past R01-type grant award
  • Faculty Member at RPCI, UPCI, University of Pittsburgh, or University at Buffalo

Women and minorities are strongly encouraged to apply for a DRP award.

Funding

The DRP will fund two to four awards of up to $40,000 for one year, with the possibility for a one-year renewal for projects with highly promising results. Second year funding is contingent on evidence of results that warrant additional support and documented in a progress report. Successful applicants are required to submit a final progress report at the end of the funding period. Funds cannot be used for salary coverage of Principal or Co-Investigators, indirect costs, travel, publications, or equipment not specifically needed for the proposed research. Salary coverage for technicians, graduate students, or postdoctoral fellows is permitted.

Successful applicants will be required to attend and occasionally present their ongoing work at monthly RPCI-UPCI Ovarian Cancer SPORE meetings, the RPCI-UPCI Ovarian Cancer SPORE annual retreat, and appropriate meetings for their respective home institutions (RPCI: GYN DSRG Meeting; UPCI: Gynecological Oncology Work in Progress meetings).

Questions

For scientific questions, please contact the DRP Principal Investigator at your institution:

RPCI: Dr. Kirsten Moysich (kirsten.moysich@roswellpark.org)

UPCI: Dr. Francesmary Modugno (modugnof@upmc.edu)

UPCI: Dr. Robert Edwards (edwarp@mail.magee.edu)

For administrative questions, please contact Dr. Amit Lugade (amit.lugade@roswellpark.org)

Deadlines

Pre-proposals: Prospective applicants are required to submit a non-binding, pre-proposal due Monday, April 17, 2017 at 5:00 pm. Pre-proposals should include the Scientific Abstract, Translational Potential, and Specific Aims. The pre-proposal is used for reviewer assignment. Therefore, specific aims, abstract and translational potential should not be significantly modified once submitted for the pre-proposal.

Full proposals including all documents listed below are due Monday, May 1, 2017 at 5:00 pm.

Document